Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Lacutamab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innate Pharma Hosts Lacutamab Event On October 28, 2025
    Innate Pharma Hosts Lacutamab Event On October 28, 2025

    14 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-14/innate-pharma-to-host-analyst-and-investor-event-on-lacutamab-on-october-28-2025

    PHARMIWEB
    14 Oct 2025
    Share Share
    Innate Pharma Reports Durable Lacutamab Results
    Innate Pharma Reports Durable Lacutamab Results

    23 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250522071107/en/Innate-Pharma-Highlights-Durable-Responses-to-Lacutamab-in-Sezary-Syndrome-and-Mycosis-Fungoides

    BUSINESSWIRE
    23 May 2025
    Share Share
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS

    17 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250216384344/en

    BUSINESSWIRE
    17 Feb 2025
    Share Share
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides

    04 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603023665/en

    BUSINESSWIRE
    04 Jun 2024
    Share Share
    Innate Pharma Announces U.S. FDA Lifts Partial Hold on Lacutamab Program
    Innate Pharma Announces U.S. FDA Lifts Partial Hold on Lacutamab Program

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240103221044/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Innate Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab
    Innate Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab

    10 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231209939521/en

    BUSINESSWIRE
    10 Dec 2023
    Share Share